Disclosure Of Fair Value Measurement [Text Block]

OSE Immunotherapeutics - Filing #880997

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
101 876 EUR
96 973 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
160,000 EUR
47 890 EUR
65 605 EUR
150,000 EUR
3 705 EUR
21 111 EUR
61 364 EUR
3 597 EUR
7 485 EUR
93,000 EUR
104,000 EUR
65 449 EUR
58 536 EUR
100,000 EUR
48 497 EUR
7 286 EUR
148,000 EUR
3 001 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.